The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 13.29

Leukemia

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2017
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to 5 >5 to 10 >10 to 15 >15 to 20 >20 to 25 <=25b >25d
All Races Both Sexes 157,262 105,314 67,081 40,842 27,001 397,501 37,481 434,982
Males 92,815 61,226 37,439 22,765 15,190 229,436 17,933 247,369
Females 64,447 44,089 29,642 18,077 11,811 168,065 19,548 187,613
White Both Sexes 135,982 92,133 59,212 36,221 24,014 347,562 31,583 379,145
Males 80,710 53,989 33,327 20,247 13,614 201,888 14,337 216,225
Females 55,272 38,144 25,884 15,974 10,400 145,674 17,246 162,920
Black Both Sexes 13,034 7,363 4,513 2,574 1,603 29,086 4,141 33,227
Males 7,121 4,011 2,347 1,288 857 15,624 1,797 17,421
Females 5,913 3,352 2,166 1,285 746 13,462 2,344 15,806
Asian/
Pacific
Islander		 Both Sexes 4,198 2,633 1,916 1,184 878 10,809 + +
Males 2,395 1,512 985 667 462 6,022 + +
Females 1,803 1,121 931 516 416 4,787 + +
Hispanic Both Sexes 15,475 10,295 7,211 4,736 3,447 41,164 + +
Males 8,703 5,760 4,028 2,528 2,013 23,031 + +
Females 6,772 4,536 3,182 2,209 1,434 18,133 + +

Estimated prevalence percent a on January 1, 2017, of the SEER population diagnosed in the previous 25 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.1226 0.0328 0.0666 0.0660 0.0413 0.0586 0.1107 0.2311 0.4153 0.5334 0.1095
Males 0.1438 0.0337 0.0738 0.0719 0.0459 0.0680 0.1352 0.2956 0.5483 0.7262 0.1355
Females 0.1022 0.0319 0.0591 0.0599 0.0367 0.0493 0.0872 0.1728 0.3041 0.4134 0.0878
White Both Sexes 0.1373 0.0364 0.0744 0.0753 0.0450 0.0611 0.1164 0.2458 0.4398 0.5658 0.1175
Males 0.1610 0.0372 0.0825 0.0812 0.0503 0.0706 0.1421 0.3122 0.5787 0.7671 0.1445
Females 0.1141 0.0355 0.0659 0.0691 0.0395 0.0514 0.0914 0.1843 0.3211 0.4382 0.0944
Black Both Sexes 0.0639 0.0154 0.0346 0.0318 0.0305 0.0484 0.0803 0.1489 0.2568 0.3116 0.0687
Males 0.0715 0.0146 0.0386 0.0356 0.0304 0.0543 0.0982 0.1866 0.3373 0.4390 0.0846
Females 0.0568 0.0162 0.0305 0.0279 0.0306 0.0432 0.0647 0.1188 0.2005 0.2479 0.0574
Asian/
Pacific
Islander		 Both Sexes 0.0518 0.0285 0.0517 0.0448 0.0248 0.0398 0.0587 0.0903 0.1325 0.1418 0.0531
Males 0.0602 0.0298 0.0552 0.0513 0.0279 0.0471 0.0693 0.1190 0.1671 0.1979 0.0635
Females 0.0441 0.0272 0.0481 0.0382 0.0220 0.0333 0.0495 0.0672 0.1049 0.1052 0.0446
Hispanic Both Sexes 0.0708 0.0370 0.0781 0.0779 0.0440 0.0522 0.0764 0.1257 0.2075 0.2243 0.0791
Males 0.0784 0.0385 0.0877 0.0870 0.0511 0.0619 0.0872 0.1425 0.2363 0.2720 0.0904
Females 0.0630 0.0355 0.0680 0.0679 0.0363 0.0422 0.0657 0.1108 0.1853 0.1948 0.0687

Footnotes:

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2017 US population estimates based on the average of 2016 and 2017 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years.

b Maximum limited-duration prevalence is 25 years for 1992-2017 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing <=25 and >25.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.